Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 973 across all filing types
Latest filing 2017-04-27 Report Publication Anno…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
Biotec Pharmacon: Q1 2017 Presentation
Report Publication Announcement Classification · 98% confidence The document text is very short (535 characters) and explicitly states that the company is presenting its 'interim report for the first quarter of 2017' and instructs the reader to 'Please find the presentation attached.' This structure—announcing the availability of a presentation/report rather than containing the full report content—strongly indicates a Report Publication Announcement (RPA), as per the 'MENU VS MEAL' rule. The content relates to an interim report (Q1 2017), but the document itself is the announcement of that report's release.
2017-04-27 English
Biotec Pharmacon: Resultater for Q1 2017
Report Publication Announcement Classification · 95% confidence The document is a short announcement (Børsmelding) from Biotec Pharmacon ASA regarding their Q1 2017 financial results. It provides a brief summary of key figures (revenue, operating profit) and mentions that the full report is attached ('Vedlagt er selskapets rapport for første kvartal 2017'). According to the 'Menu vs Meal' rule, since this is a short announcement referencing an attached report rather than the full financial report itself, it is classified as a Report Publication Announcement (RPA). Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon: Resultater for Q1 2017
Report Publication Announcement Classification · 95% confidence The document is a short announcement (approx. 3,200 characters) titled 'Biotec Pharmacon: Resultater for Q1 2017'. While it provides a brief summary of financial highlights, the final paragraph explicitly states 'Vedlagt er selskapets rapport for første kvartal 2017' (Attached is the company's report for the first quarter of 2017). According to the 'Menu vs Meal' rule, a short document that announces the availability of a report and states it is attached is classified as a Report Publication Announcement (RPA). Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon ASA: Invitation to presentation of Q1 2017 results
Report Publication Announcement Classification · 98% confidence The document is titled 'Biotec Pharmacon ASA: Invitation to presentation of Q1 2017 results'. It explicitly invites recipients to a presentation regarding the Q1 2017 results and states that the 'interim report for the first quarter 2017 will be available' at a specific time and location. Since the document is an invitation/announcement about the release of the results report, rather than the full report itself, it fits the definition of a Report Publication Announcement (RPA). The document length (1011 chars) is very short, supporting the RPA classification over the comprehensive Interim Report (IR).
2017-04-21 English
Biotec Pharmacon ASA: Notice of ordinary general meeting
AGM Information Classification · 100% confidence The document text is explicitly titled 'INNKALLING TIL ORDINÆR GENERALFORSAMLING' (NOTICE OF ANNUAL GENERAL MEETING) in Norwegian and 'NOTICE OF ANNUAL GENERAL MEETING' in English. The content details the date, time, location, and the specific agenda items (saker/matters) to be addressed at this meeting, such as approving the annual report, electing board members, and authorizing share issues. This content perfectly matches the definition of materials shared during an Annual General Meeting. Therefore, the classification is AGM-R.
2017-04-20 English
Biotec Pharmacon ASA: Notice of ordinary general meeting
AGM Information Classification · 98% confidence The document is titled 'Biotec Pharmacon ASA: Notice of ordinary general meeting' and explicitly mentions the date and location for the meeting. It states that the 'notice and agenda for the meeting' are enclosed and that shareholders should register. This content directly relates to the logistics and announcement of the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length is short (1101 chars), but the content is the notice itself, not just an announcement that the notice is available, making AGM-R more specific than RPA or RNS.
2017-04-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.